GBS (GBS) Competitors

GBS (NYSE:GBS) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

Do analysts rate GBS or NSPR?

InspireMD has a consensus price target of $4.50, indicating a potential upside of 80.00%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than GBS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GBS	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk & volatility, GBS or NSPR?

GBS has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Is GBS or NSPR more profitable?

GBS has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat GBS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GBS	N/A	-85.64%	-54.42%
InspireMD	-413.96%	-69.42%	-57.68%

Does the media refer more to GBS or NSPR?

In the previous week, GBS had 2 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for GBS and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.95 beat GBS's score of -0.04 indicating that InspireMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GBS	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in GBS or NSPR?

2.8% of GBS shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 0.3% of GBS shares are held by company insiders. Comparatively, 34.1% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has better valuation & earnings, GBS or NSPR?

GBS has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than GBS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GBS	N/A	N/A	-$8.31M	-$0.56	-2.64
InspireMD	$7.07M	14.76	-$19.92M	-$0.83	-3.01

Summary

InspireMD beats GBS on 8 of the 15 factors compared between the two stocks.